KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels.
about
Hierarchical scaffolding of an ERK1/2 activation pathwayGenetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10.Suppression of Ras/Mapk pathway signaling inhibits Myc-induced lymphomagenesis.AMPK Promotes Aberrant PGC1β Expression To Support Human Colon Tumor Cell Survival.Endometrial carcinoma: molecular alterations involved in tumor development and progression.Molecular pathology of endometrial carcinoma.FLIP: molecular switch between apoptosis and necroptosis.Functional genomics identifies novel genes essential for clear cell renal cell carcinoma tumor cell proliferation and migration.Endometrial Carcinoma: Specific Targeted Pathways.Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells.Sorafenib induces endometrial carcinoma apoptosis by inhibiting Elk-1-dependent Mcl-1 transcription and inducing Akt/GSK3β-dependent protein degradation.ERK controls epithelial cell death receptor signalling and cellular FLICE-like inhibitory protein (c-FLIP) in ulcerative colitis.The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.Expression of the scaffold connector enhancer of kinase suppressor of Ras 1 (CNKSR1) is correlated with clinical outcome in pancreatic cancer.praja2 regulates KSR1 stability and mitogenic signalingGenetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer.Cellular FLICE-like inhibitory protein protects against cardiac hypertrophy by blocking ASK1/p38 signaling in mice.
P2860
Q28578122-C03B24FC-AF47-4226-B780-EF6B0A2395E1Q35561369-BC5432D8-101E-4D22-9B2A-E9433BB0953CQ36028499-63EF09A2-E27C-4CAE-8216-EC136DEF7187Q36174103-83BA437F-DCD8-47EB-81B2-E578E3A8923AQ37994980-B29123D8-8AD8-45E5-A41B-1941260EE03DQ38067440-8855296C-B9D2-4264-9A03-B48E9305CDCEQ38102627-489F8800-4BD6-437C-A1BF-C8C0175E0960Q38979602-5ABECF9A-4102-4B86-84F4-FDC6FB2223E5Q39026766-25FC31DA-32F2-4994-9B94-37E79C3DCBD7Q39165456-57D75189-57DC-4E8F-84A2-B36D3ED189C7Q39184863-B80263C1-A706-4626-8B6E-ED066BC239DDQ39201238-D536F310-55A2-4F56-B0DF-0AC3857141BFQ40343618-D3926236-1C0C-4481-8855-F58115D0E617Q41095719-999D9074-D188-4628-AC34-5853D0C8AA57Q42563084-D14D365D-3823-4641-8700-F29BD6A25FFAQ46776621-F0F20C09-7933-4869-A8E3-88647344FA48Q55072312-C2158D24-518D-4B5F-97BD-94D1BFA17632
P2860
KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
KSR1 is overexpressed in endom ...... sis by modulating FLIP levels.
@ast
KSR1 is overexpressed in endom ...... sis by modulating FLIP levels.
@en
KSR1 is overexpressed in endom ...... sis by modulating FLIP levels.
@nl
type
label
KSR1 is overexpressed in endom ...... sis by modulating FLIP levels.
@ast
KSR1 is overexpressed in endom ...... sis by modulating FLIP levels.
@en
KSR1 is overexpressed in endom ...... sis by modulating FLIP levels.
@nl
prefLabel
KSR1 is overexpressed in endom ...... sis by modulating FLIP levels.
@ast
KSR1 is overexpressed in endom ...... sis by modulating FLIP levels.
@en
KSR1 is overexpressed in endom ...... sis by modulating FLIP levels.
@nl
P2093
P2860
P50
P1476
KSR1 is overexpressed in endom ...... sis by modulating FLIP levels.
@en
P2093
Andree Yeramian
Anna Macià
Cristina Mirantes
David Llobet
Jose Palacios
Judit Pallares
Laura Bergada
Monica Domingo
Nuria Eritja
Robert E Lewis
P2860
P304
P356
10.1016/J.AJPATH.2010.12.041
P407
P577
2011-04-01T00:00:00Z